TABLE V.
Comparison of RCTs from 2014 to 2022 with RCTs from 1998 to 2000 and from 2001 to 2013*
1988-2000 | 2001-2013 | 2014-2022 | P Value | |
---|---|---|---|---|
No. of published trials | 72 | 285 | 218 | |
Publications per year | 5.5 | 21.9 | 24.2 | 0.261 |
Mean transformed Detsky score† | 68.1% ± 1.6% | 76.2% ± 0.7% | 84.6% ± 9.6% | <0.001 |
Mean modified risk-of-bias score† | NR | 6.40 ± 0.71 | 7.3 ± 1.3 | <0.001 |
Trials reporting positive results‡ | 81.9% | 50.5% | 65.1% | <0.001 |
Multicenter trials‡ | 67% | 31% | 33.0% | <0.001 |
Reported receiving funding‡ | 56.9% | 52.6% | 47.2% | 0.263 |
Sample size§ | NR | 165.6 (17.9) | 156.8 (12.5) | 0.705 |
Trials reporting an a priori power analysis‡ | NR | 67.7% | 83.9% | <0.001 |
Study type (no. [%] of trials) | <0.001 | |||
Surgical | 30 (41.7%) | 183 (64.2%) | 162 (74.3%) | |
Nonsurgical | 16 (22.2%) | 45 (15.8%) | 38 (17.4%) | |
Drug | 26 (36.1%) | 57 (20.0%) | 18 (8.3%) |
NR = not reported. Bold indicates significance.
Values are given as the mean ± standard deviation.
Values are given as the proportion of the total number of published studies for that period.
Values are given as the mean, with the standard error in parentheses.